| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448292 Comprising a diglyceride in which at least 55% by weight of constitutive acyl groups are unsaturated acyl groups and 15 to 100% by weight thereof are omega 3 type unsaturated acyl groups having at least 20 carbon atoms and a triglyceride |
| 09/10/2002 | US6448291 Controlling phytopathogenic fungi |
| 09/10/2002 | US6448288 Cannabinoid drugs |
| 09/10/2002 | US6448287 Enhanced efficacy of sodium ascorbate against three dimensional in vitro tumors and in mouse tumors; safe |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia |
| 09/10/2002 | US6448284 Substituted tricyclics |
| 09/10/2002 | US6448283 Fused pyrrolocarbazoles; hearing loss and loss of the sense of balance |
| 09/10/2002 | US6448282 1H-4(5)-substituted imidazole derivatives |
| 09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
| 09/10/2002 | US6448280 Such as 2-butyl-4-chloro-5-hydroxymethyl-1-((2'-(1h-tetrazol-5-yl) iphenyl-4-yl)me thyl)imidazole; |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448275 Side effect reduction |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448272 Myt1 kinase inhibitors |
| 09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
| 09/10/2002 | US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
| 09/10/2002 | US6448268 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448266 Substituted cyclobutylamine derivatives |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity |
| 09/10/2002 | US6448258 Heterocyclic amine compounds |
| 09/10/2002 | US6448256 Precursors of n-substituted derivatives of 6-aminouracils, 6-aminoisocytosines, guanines and 2-aminoadenines having a cleavable ester group; greater water solubility and oral bioavailability; treating gram positive bacterial infections |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6448253 Adenosine A3 receptor modulators |
| 09/10/2002 | US6448252 Treatment of equine protozoal myeloencephalitis |
| 09/10/2002 | US6448251 Zwitterionic-fatty acid compounds having anti-inflammatory properties |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| 09/10/2002 | US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?) |
| 09/10/2002 | US6448245 Methods of and compounds for inhibiting calpains |
| 09/10/2002 | US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually |
| 09/10/2002 | US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia |
| 09/10/2002 | US6448242 Cyclic amide compounds |
| 09/10/2002 | US6448239 Porphyrin ring metallic complexes that are effective peroxynitrite decomposition catalysts for treatment of diseases involving the accumulation of this oxidant, such as altzeimer's disease |
| 09/10/2002 | US6448238 Inhibitors of β-lactamases and uses therefor |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448235 Agonists of a2a adenosine receptors in combination with rolipram, its derivatives or other type iv phosphodiesterase (pde) inhibitor are effective for the treatment of inflammatory diseases |
| 09/10/2002 | US6448233 System for dispensing benzoyl peroxide and macrolide or aminoglycoside antibiotic for treatment of acne wherein each is present in a high concentration and dispensing causes mixing to achieve desired concentration for topical use |
| 09/10/2002 | US6448232 Specifically phlorizin to block the intestinal absorption of glucose and renal tubule resorption of glucose as treatment for diabetes and obesity; increase elimination of sodium and lithium |
| 09/10/2002 | US6448229 Gamma secretase inhibitors |
| 09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
| 09/10/2002 | US6448093 Solubilization of hyaluronic acid in aqueous solution of electrolyte and acid; solubilization of polar substancec (i.e. a plasmid) in mixture; acidification; dialyzing said mixture to reduce an ionic concentration past point of collapse |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448074 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/10/2002 | US6447819 Water-soluble complex of an extract of Ginkgo biloba, process for the preparation thereof and composition comprising the same |
| 09/10/2002 | US6447818 Compositions containing compounds with adrenergic activity and vegetable extracts of Crataegus and gingko biloba for the treatment of overweight and obesity |
| 09/10/2002 | US6447817 Anti-inflammatory analgesic |
| 09/10/2002 | US6447814 Plant extracts used for prevention of cardiovascular disorders, obtained by solvent extraction, heating, filtration and condensation, then encapsulation to form particles; side effect reduction |
| 09/10/2002 | US6447812 Dietetics; mixture of oat bran, glucosamine hydrochloride, glucomannan and pectin |
| 09/10/2002 | US6447810 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 09/10/2002 | US6447809 Composition for promoting healthy bone structure |
| 09/10/2002 | US6447807 Coating and casing powders in acid resistant hydrophobic polymers to produce moisture proof, durable and workable particles; drug delivery; dietetics |
| 09/10/2002 | US6447801 Comprising liposomes having phosphotide membranes enclosing water soluble anthelmintic drugs used as insect repellants and for prevention of schistosomiasis |
| 09/10/2002 | US6447790 Oily material composition |
| 09/10/2002 | US6447787 Methods for enhancing wound healing |
| 09/10/2002 | US6447758 Cationic antibacterial dentifrice exhibiting superior foaming properties |
| 09/10/2002 | US6447754 Aqueous ingestible solution of calcium glycerophosphate |
| 09/10/2002 | US6447753 Biodegradable material |
| 09/10/2002 | US6447752 Amorphous porous particles for deep lung delivery |
| 09/10/2002 | US6447750 Medicinal aerosol formulation |
| 09/10/2002 | US6447748 Benzamide compounds for cancer imaging and therapy |
| 09/10/2002 | CA2402544A1 Lipopolysaccharides (lps) extracted from escherichia coli |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/10/2002 | CA2275732C Etiological treatment method for treating cancer and viral infections using fungicides |
| 09/10/2002 | CA2260852C Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 09/10/2002 | CA2258661C Synthetic phosphopeptides for treating bone diseases |
| 09/10/2002 | CA2250844C Anti-hiv composition comprising imidazole derivatives |
| 09/10/2002 | CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors |
| 09/10/2002 | CA2239159C Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides |
| 09/10/2002 | CA2219654C Compositions and methods for stimulating hair growth |
| 09/10/2002 | CA2200481C Method and means for prevention and treatment of secondary cataract |
| 09/10/2002 | CA2198562C Method of treating conditions with estrogen agonists |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/10/2002 | CA2192208C Substituted pyrazoles |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 09/10/2002 | CA2119853C Pyridothiadiazines; process for preparing the same and pharmaceutical compositions containing them |
| 09/10/2002 | CA2087967C Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 09/10/2002 | CA2083766C Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained |
| 09/10/2002 | CA2053933C Nutritional composition comprising hydrolysed soluble fiber |
| 09/10/2002 | CA2039643C Anti-wart composition |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002069369A2 Cpg-like nucleic acids and methods of use thereof |
| 09/06/2002 | WO2002068930A2 Methods and reagents to acquire mri signals and images |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068561A2 Cubic liquid crystalline phase precursor |
| 09/06/2002 | WO2002068548A1 Use of erss-selective ligands for regulating fertility and compounds useful therefore |
| 09/06/2002 | WO2002068477A1 Highly sulfated derivatives of k5 polysaccharide and their preparation |